Michael Jeffrey Abrams
Oprichter bij Abdera Therapeutics, Inc.
Actieve functies van Michael Jeffrey Abrams
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
University of British Columbia | Corporate Officer/Principal | - | - |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Directeur/Bestuurslid | 02-09-2009 | - |
TRIUMF Innovations, Inc.
TRIUMF Innovations, Inc. Information Technology ServicesTechnology Services TRIUMF Innovations, Inc. is the business interface and commercialization arm of TRIUMF, Canada's particle accelerator center. The private company is based in Vancouver, Canada. The Canadian company connects TRIUMF to the private sector through industry partnerships, licensing, and company creation. Kathryn Hayashi has been the CEO of the company since 2017. | Directeur/Bestuurslid | - | - |
SaNOtize Research & Development Corp.
SaNOtize Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services SaNOtize Research & Development Corp operates as a biotech company. The firm develops antimicrobial and immunomodulation technology to treat and prevent microbial infections, including drug resistant microbes. The company was founded by Gilly Regev and Chris Miller and is headquartered in Vancouver, Canada. | Directeur/Bestuurslid | - | - |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Oprichter | 01-01-2020 | - |
Corporate Officer/Principal | 01-01-2014 | - |
Loopbaan van Michael Jeffrey Abrams
Eerdere bekende functies van Michael Jeffrey Abrams
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NERVGEN PHARMA CORP. | Directeur/Bestuurslid | 21-08-2018 | 13-04-2022 |
Independent Dir/Board Member | 21-08-2018 | 13-04-2022 | |
ARBUTUS BIOPHARMA CORPORATION | Directeur/Bestuurslid | 02-09-2009 | 16-06-2014 |
Independent Dir/Board Member | 17-10-2011 | 16-06-2014 | |
Corporate Officer/Principal | - | 30-09-2016 | |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Voorzitter | 02-09-2009 | 01-01-2013 |
CDRD Ventures, Inc.
CDRD Ventures, Inc. Pharmaceuticals: MajorHealth Technology CDRD Ventures, Inc. engages in the development and production of therapeutic products. The company is headquartered in Vancouver, Canada. | Hoofd Techniek/Wetenschap/O&O | 01-09-2012 | 01-01-2013 |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | - | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Michael Jeffrey Abrams
Massachusetts Institute of Technology | Doctorate Degree |
Bowdoin College | Undergraduate Degree |
Statistieken
Internationaal
Canada | 13 |
Verenigde Staten | 4 |
Verenigd Koninkrijk | 2 |
Operationeel
Director/Board Member | 7 |
Corporate Officer/Principal | 4 |
Independent Dir/Board Member | 2 |
Sectoraal
Health Technology | 10 |
Consumer Services | 3 |
Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
JOHNSON MATTHEY PLC | Process Industries |
NERVGEN PHARMA CORP. | Health Technology |
Bedrijven in privébezit | 10 |
---|---|
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Health Technology |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
Inimex Pharmaceuticals, Inc.
Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Health Technology |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Commercial Services |
CDRD Ventures, Inc.
CDRD Ventures, Inc. Pharmaceuticals: MajorHealth Technology CDRD Ventures, Inc. engages in the development and production of therapeutic products. The company is headquartered in Vancouver, Canada. | Health Technology |
TRIUMF Innovations, Inc.
TRIUMF Innovations, Inc. Information Technology ServicesTechnology Services TRIUMF Innovations, Inc. is the business interface and commercialization arm of TRIUMF, Canada's particle accelerator center. The private company is based in Vancouver, Canada. The Canadian company connects TRIUMF to the private sector through industry partnerships, licensing, and company creation. Kathryn Hayashi has been the CEO of the company since 2017. | Technology Services |
SaNOtize Research & Development Corp.
SaNOtize Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services SaNOtize Research & Development Corp operates as a biotech company. The firm develops antimicrobial and immunomodulation technology to treat and prevent microbial infections, including drug resistant microbes. The company was founded by Gilly Regev and Chris Miller and is headquartered in Vancouver, Canada. | Commercial Services |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Health Technology |